SCHEMBL4925525

SCHEMBL4925525

O=C(Cc1cccnc1)Nc1ccc(-c2ccc(C(=O)C3CCCC3C(=O)O)nc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.49
PDE3B Q13370 1/20 0.48
WNT3A P56704 1/20 0.48
PORCN Q9H237 1/20 0.46
DGAT1 O75907 5/20 0.45
MAP4K4 O95819 1/20 0.44
ABL1 P00519 1/20 0.44
NTRK1 P04629 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
CSF1R P07333 1/20 0.44
RET P07949 1/20 0.44
IGF1R P08069 1/20 0.44
PDGFRB P09619 1/20 0.44
FGFR1 P11362 1/20 0.44
FLT1 P17948 1/20 0.44
LTK P29376 1/20 0.44
KDR P35968 1/20 0.44
FLT3 P36888 1/20 0.44
CLK2 P49760 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4925492 1.00 HRH3 (0.49) HRH3PDE3BWNT3APORCNDGAT1
SCHEMBL4925511 1.00 HRH3 (0.49) HRH3PDE3BWNT3APORCNDGAT1
SCHEMBL4924495 0.91 DGAT1 (0.52) WNT3ADGAT1CDK5LMNARAB9A
SCHEMBL4924505 0.91 DGAT1 (0.52) WNT3ADGAT1CDK5LMNARAB9A
SCHEMBL4924500 0.91 DGAT1 (0.52) WNT3ADGAT1CDK5LMNARAB9A
SCHEMBL4922361 0.84 DGAT1 (0.43) WNT3APORCNDGAT1ROCK2LMNA
SCHEMBL4922360 0.84 DGAT1 (0.43) WNT3APORCNDGAT1ROCK2LMNA
SCHEMBL4922356 0.84 DGAT1 (0.43) WNT3APORCNDGAT1ROCK2LMNA
SCHEMBL4916334 0.83 RAB9A (0.45) DGAT1LMNARAB9A
SCHEMBL4916306 0.83 RAB9A (0.45) DGAT1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US claimed
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme DGAT1, DGAT2, DLAT HRH3 3588/4885PDE3B 919/4885WNT3A 3446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.